TREY PIRKEY: Open Payments
NPI 1457553422 · NEW BOSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$821 in 39 payments from 13 companies in 2025. Trend: 2023 $871 · 2024 $598 · 2025 $821
Food & beverage: $821
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $161 |
| ABBVIE INC. | 10 | $142 |
| Antares Pharma, Inc. | 1 | $102 |
| Lilly USA, LLC | 1 | $85 |
| Lundbeck LLC | 3 | $80 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| Exact Sciences Corporation | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Novo Nordisk Inc | 2 | $31 |
| Verona Pharma, Inc. | 1 | $18 |
Products named: TRELEGY ELLIPTA, XYOSTED, MOUNJARO, VYEPTI, UBRELVY, Cologuard Collection Kit, VRAYLAR, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
